Bristol Myers Valuation
| BMY Stock | MXN 744.63 2.13 0.29% |
At this time, the firm appears to be overvalued. Bristol Myers Squibb shows a prevailing Real Value of 588.26 per share. The current price of the firm is 744.63. Our model approximates the value of Bristol Myers Squibb from analyzing the firm fundamentals such as Return On Equity of 0.18, profit margin of 0.14 %, and Current Valuation of 3.9 T as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor acquiring undervalued instruments and dropping overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Overvalued
Today
Please note that Bristol Myers' price fluctuation is very steady at this time. Calculation of the real value of Bristol Myers Squibb is based on 3 months time horizon. Increasing Bristol Myers' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Bristol Myers Squibb is useful when determining the fair value of the Bristol stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Bristol Myers. Since Bristol Myers is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bristol Stock. However, Bristol Myers' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 744.63 | Real 588.26 | Hype 744.63 |
The real value of Bristol Stock, also known as its intrinsic value, is the underlying worth of Bristol Myers Squibb Company, which is reflected in its stock price. It is based on Bristol Myers' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Bristol Myers' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Bristol Myers' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Bristol Myers Squibb helps investors to forecast how Bristol stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bristol Myers more accurately as focusing exclusively on Bristol Myers' fundamentals will not take into account other important factors: Bristol Myers Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Bristol Myers's current stock value. Our valuation model uses many indicators to compare Bristol Myers value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bristol Myers competition to find correlations between indicators driving Bristol Myers's intrinsic value. More Info.Bristol Myers Squibb is rated second in price to earning category among related companies. It is rated second in price to book category among related companies fabricating about 0.02 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Bristol Myers Squibb is roughly 48.67 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Bristol Myers by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bristol Myers' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bristol Myers' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Bristol Myers' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Bristol Myers and how it compares across the competition.
About Bristol Myers Valuation
The stock valuation mechanism determines the current worth of Bristol Myers Squibb on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Bristol Myers Squibb. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Bristol Myers Squibb based exclusively on its fundamental and basic technical indicators. By analyzing Bristol Myers's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Bristol Myers's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bristol Myers. We calculate exposure to Bristol Myers's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bristol Myers's related companies.Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. BRISTOL MYERS operates under Drug Manufacturers - Major classification in Mexico and is traded on Mexico Stock Exchange. It employs 23300 people.
8 Steps to conduct Bristol Myers' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Bristol Myers' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Bristol Myers' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Bristol Myers' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Bristol Myers' revenue streams: Identify Bristol Myers' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Bristol Myers' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Bristol Myers' growth potential: Evaluate Bristol Myers' management, business model, and growth potential.
- Determine Bristol Myers' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Bristol Myers' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bristol Myers Squibb. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for Bristol Stock analysis
When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |